These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1409374)

  • 1. Quantitative evaluation of aqueous isopropanol enhancement of skin flux of terbutaline (sulfate). I. Ion associations and species equilibria in the formulation.
    Liu P; Kurihara-Bergstrom T; Clarke FH; Gonnella N; Good WR
    Pharm Res; 1992 Aug; 9(8):1035-42. PubMed ID: 1409374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative evaluation of aqueous isopropyl alcohol enhancement on skin flux of terbutaline (sulfate). 2. Permeability contributions of equilibrated drug species across human skin in vitro.
    Liu P; Bergstrom TK
    J Pharm Sci; 1996 Mar; 85(3):320-5. PubMed ID: 8699337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pH and organic ester penetration enhancers on skin permeation kinetics of terbutaline sulfate from pseudolatex-type transdermal delivery systems through mouse and human cadaver skins.
    Panigrahi L; Pattnaik S; Ghosal SK
    AAPS PharmSciTech; 2005 Sep; 6(2):E167-73. PubMed ID: 16353974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terbutaline transdermal delivery: preformulation studies and limitations of in-vitro predictive parameters.
    Tenjarla S; Puranajoti P; Kasina R; Mandal T
    J Pharm Pharmacol; 1996 Nov; 48(11):1138-42. PubMed ID: 8961161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iontophoretic transdermal delivery of salbutamol: methyl-orange ion-pair.
    Sant VP; Khopade AJ; Jain NK
    Pharmazie; 1998 May; 53(5):334-6. PubMed ID: 9631502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of an extemporaneously compounded terbutaline sulfate oral liquid.
    Horner RK; Johnson CE
    Am J Hosp Pharm; 1991 Feb; 48(2):293-5. PubMed ID: 2003504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of carboxymethyl guar films for the formulation of transdermal therapeutic systems.
    Narasimha Murthy S; Hiremath SR; Paranjothy KL
    Int J Pharm; 2004 Mar; 272(1-2):11-8. PubMed ID: 15019064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcutaneous overdose of terbutaline.
    Ingrams GJ; Morgan FB
    BMJ; 1993 Aug; 307(6902):484. PubMed ID: 8400938
    [No Abstract]   [Full Text] [Related]  

  • 9. Skin permeability of tulobuterol in two transdermal formulations and their followability.
    Takizawa Y; Goto T; Sato S; Ohmori N; Mori K; Shimada Y; Chen K; Miyagi T; Fukai F
    Drug Discov Ther; 2017 Nov; 11(5):253-258. PubMed ID: 29021505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of terbutaline and salbutamol in plasma by high performance liquid chromatography with fluorescence detection.
    McCarthy PT; Atwal S; Sykes AP; Ayres JG
    Biomed Chromatogr; 1993; 7(1):25-8. PubMed ID: 8431676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular assembly of the ionic liquid/aliphatic carboxylic acid/aliphatic amine as effective and safety transdermal permeation enhancers.
    Kubota K; Shibata A; Yamaguchi T
    Eur J Pharm Sci; 2016 Apr; 86():75-83. PubMed ID: 26965004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chromatographic conditions on liquid chromatographic chiral separation of terbutaline and salbutamol on Chirobiotic V column.
    Hashem H; Tründelberg C; Attef O; Jira T
    J Chromatogr A; 2011 Sep; 1218(38):6727-31. PubMed ID: 21855076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic/pharmacodynamic characteristics of the beta-2-agonists terbutaline, salbutamol and fenoterol.
    Hochhaus G; Möllmann H
    Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):342-62. PubMed ID: 1358833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermodynamic study of the interaction between terbutaline and salbutamol with an immobilized beta(2)-adrenoceptor by high-performance liquid chromatography.
    Zhao X; Zheng X; Wei Y; Bian L; Wang S; Zheng J; Zhang Y; Li Z; Zang W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(10):911-8. PubMed ID: 19269265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting the release rate of terbutaline from liposome formulations after intratracheal instillation in the guinea pig.
    Fielding RM; Abra RM
    Pharm Res; 1992 Feb; 9(2):220-3. PubMed ID: 1553346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise increases the rate of pulmonary absorption of inhaled terbutaline.
    Schmekel B; Borgström L; Wollmer P
    Chest; 1992 Mar; 101(3):742-5. PubMed ID: 1541141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of the enantiomers of terbutaline after repeated oral dosing with racemic terbutaline.
    Borgström L; Liu CX; Walhagen A
    Chirality; 1989; 1(2):174-7. PubMed ID: 2642046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human skin permeability enhancement by lauric acid under equilibrium aqueous conditions.
    Smith SW; Anderson BD
    J Pharm Sci; 1995 May; 84(5):551-6. PubMed ID: 7658343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative absorption of the two enantiomers of terbutaline after duodenal administration.
    Borgström L; Kennedy BM; Nilsson B; Angelin B
    Eur J Clin Pharmacol; 1990; 38(6):621-3. PubMed ID: 2373137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemiluminescence determination of terbutaline sulfate in bovine urine and pharmaceutical preparations based on enhancement of the 2-phenyl-4, 5-di (2-furyl) imidazole-potassium ferricyanide system.
    Han L; Zhang Y; Kang J; Tang J; Zhang Y
    J Pharm Biomed Anal; 2012 Jan; 58():141-5. PubMed ID: 21996060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.